Changes in Beneficial Ownership · 4
Transcat, Inc.
TRNSNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
form4.xml
Filing details
- Report period
- 2026-08-07
- Issuer
- TRANSCAT INC
- Issuer CIK
- 0000099302
- Trading symbol
- TRNS
Reporting owner 1
- Name
- Gillette Christopher P.
- Reporting owner CIK
- 0001991954
- Relationship
- Director
- Address
- C/O TRANSCAT, INC., 35 VANTAGE POINT DRIVE, ROCHESTER, NY, 14624
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, $.50 par value | 2026-08-07 | S · Form 4 | 504 | D | 94.2345 | 200 | D |
Table key
- S · Form 4
- Sale on the market or privately
- D
- Direct
Derivative holdings
| Security | Conversion / exercise price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Amount owned | Ownership |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units | 0[F1] | [F1] | [F1] | Common Stock, $.50 par value | 1,587 | 1,587 | D |
| Stock Option (Right to Buy) | 109.55 | [F2] | 2033-09-06 | Common Stock, $.50 par value | 10,000 | 10,000 | D |
Table key
- D
- Direct
Footnotes
- F1
- These restricted stock units, which convert into common stock on a one-for-one basis, vest on September 10, 2026, except as otherwise provided in the award agreement.↩ 1↩ 2↩ 3
- F2
- This option vests and becomes exercisable pro rata with respect to one-fifth of the shares subject to the option on the first, second, third, fourth and fifth anniversaries of the date of grant, except as otherwise provided in the award agreement.↩ 1
Remarks
Exhibit 24 - Power of Attorney
Signature 1
- Signed
- /s/ Christopher P. Gillette
- Date
- 2026-08-12
Filed exhibits
- GILLETTE POA ↗exhibit24-1.txt
Company context
Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its Calibration Service Centers strategically located across the United States and Internationally. In addition, Transcat operates calibration labs in imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.